Primary Care/Hospitalist
RSSArticles
-
Pharmacology Watch - Full November 1, 2009 Issue in PDF
-
Bell's palsy: Corticosteroids and/or antivirals?
-
CDC issues new vaccine recommendations
-
Use of SSRIs during pregnancy
-
STD Quarterly: HIV vaccine update: Progress made, but more work is left to do in research
Encouraging news comes from the HIV vaccine research front, where an investigational vaccine regimen tested in a Thailand clinical trial has been shown to be well tolerated and to have a modest effect in preventing HIV infection. -
Update care of pregnant women in light of H1N1
As the United States gears up to combat the H1N1 flu (also known as swine flu), be sure your practice includes the latest Centers for Disease Control and Prevention (CDC) recommendations for care of pregnant women. -
Medical abortion: Safety, access probed
If medical abortion using mifepristone (Mifeprex, Danco Group) and misoprostol is offered at your facility, be sure to review a new study that asserts the safety of a particular mifepristone/misoprostol regimen. -
Options for treatment of heavy bleeding in focus
Clinicians now have an approved indication in hand for use of the levonorgestrel intrauterine system Mirena (LNG IUS, Mirena, Bayer HealthCare Pharmaceuticals; Wayne, NJ), to treat heavy menstrual bleeding in women who use intrauterine contraception as their method of pregnancy prevention. -
Gardasil approved for use in males — Cervarix gets OK for use in females
Two new actions from the Food and Drug Administration (FDA) will impact your practice. -
Recession impacts women's choices — How is your facility responding?
Check the records of women who are scheduled to return to your facility for a contraceptive refill or annual well woman exam. Are you seeing empty spots in the schedule?